An R&D team consisting of experts takes care of the entire cycle of pharmaceutical development from planning and research performance to item approval, contributing to the achievement of project goals.
Research Areas
| Development of incrementally modified drugs (IMD) | The goal is to study IMD with safety, efficacy, usability, and progressiveness. |
|---|---|
| Development of generic drugs | The goal is to develop generic drugs with reliability through verification of bioequivalence. |
| Development of individual raw materials for dietary supplements | The goal is to develop raw materials verified to have new functionality using an exclusive development process. |
R&D Network
Since its establishment, Richwood has emphasized the importance of co-prosperity and cooperation for over 40 years. It has been building a tight network with other pharmaceutical manufacturers, contract research organizations (CROs), and excellent South Korean research institutes. Richwood also opened the Richwood R&D Center within the College of Pharmacy at Seoul National University, continuing the active exchange of excellent talents and resources and sharing knowledge and information. Through this, it has positioned itself at the center of the R&D network in the pharmaceutical industry encompassing the industry and academe.
| Contract Research Organization | Develop items with verified effectiveness by conducting joint clinical tests and live tests with various CROs. |
|---|---|
| University | Conclude memoranda of understanding (MoU) with major colleges of pharmacy and operate industry-academe programs that support the preliminary research projects of new researchers. |
| Pharmaceutical Company | Develop ODM items using R&D capabilities and perform the CMO business for OEM items through specialized manufacturing facilities. |
| Research Institute | Operate joint research programs such as jointly participating in national research projects and supporting the commercialization of early-stage research projects |